基于免疫信息学方法设计一种针对SARS-CoV-2变异的多表位疫苗
Ibrahim Farhani1, Ahad Yamchi2, Hamid Madanchi3
1Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Golestan University of Medical Sciences, Gorgan, Iran.
Current computer-aided drug design
|June 13, 2023
概括
使用免疫信息学工具设计了一种新型多表位疫苗 (MEV),以向SARS-CoV-2的保存区域. 这种安全有效的候选疫苗显示出对当前和未来的变种的承诺.
科学领域:
- 疫苗学 疫苗学 疫苗学
- 计算生物学 计算生物学
- 免疫学 免疫学 免疫学
背景情况:
- SARS-CoV-2 构成了严重的全球健康威胁,新出现的变种降低了疫苗的有效性.
- 预计未来会有疫情爆发,需要强大而适应性的疫苗策略.
研究的目的:
- 设计一种安全且具有保护性的多表位疫苗 (MEV),针对SARS-CoV-2的保护区域.
- 开发一种针对所有冠状病毒物种和变种有效的疫苗.
主要方法:
- 生物信息分析,以确定从尖端和核囊蛋白质中保存的表位.
- 对表位抗原性,毒性和过敏性进行in silico评估.
- 分子对接和动态模拟以评估疫苗-受体相互作用和稳定性.
- 在Saccharomyces boulardii表达的Codon优化.
主要成果:
- 确定了保存,安全和抗原性表位,人口覆盖率为74.83%.
- 设计的MEV显示稳定性 (不稳定性指数38.61) 和强大的结合亲和力TLR2和TLR4.
- 在 silico 模拟中预测了幽默和细胞免疫的诱导.
结论:
- 在分析证实了设计的MEV作为对SARS-CoV-2变种的有希望的保护性疫苗.
- 这一战略为未来的冠状病毒爆发提供了潜在的解决方案.
相关概念视频
Conjugated Proteins
18.4K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
18.4K
Cross-reactivity
31.3K
Overview
31.3K


